- Home
- TAK vs KB Comparison
TAK vs KB Comparison
Compare TAK & KB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TAK | KB |
|---|---|---|
| Founded | 1781 | 2008 |
| Country | Japan | South Korea |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 55.1B | 42.2B |
| IPO Year | 2007 | 2008 |
Fundamental Metrics
Financial Performance| Metric | TAK | KB |
|---|---|---|
| Price | $17.39 | $120.38 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 3.8M | 219.5K |
| Earning Date | 05-13-2026 | 04-23-2026 |
| Dividend Yield | ★ 3.24% | 2.31% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $0.16 | $18.22 |
| Revenue Next Year | $1.22 | $3.21 |
| P/E Ratio | $41.25 | ★ $9.90 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.99 | $76.31 |
| 52 Week High | $18.90 | $125.66 |
Technical Indicators
Market Signals| Indicator | TAK | KB |
|---|---|---|
| Relative Strength Index (RSI) | 56.16 | 55.20 |
| Support Level | $16.15 | $114.71 |
| Resistance Level | $17.83 | $125.64 |
| Average True Range (ATR) | 0.24 | 2.07 |
| MACD | 0.00 | -0.39 |
| Stochastic Oscillator | 71.57 | 65.22 |
Price Performance
Historical ComparisonAbout TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.5 trillion in fiscal 2025. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with about 50% from the US, 10% from Japan, 25% from Europe, and 15% from Canada.
About KB KB Financial Group Inc
KB Financial Group Inc. is a financial holding company in Korea. The company operations include Kookmin Bank, one of the commercial banks in Korea. The company's subsidiaries collectively engage in a broad range of businesses, including commercial banking, credit cards, asset management, non-life and life insurance, capital markets activities, and international banking and finance. The company's segments include the Banking business, Securities business, Non-life Insurance business, Credit card business, and Life Insurance business. The Group generates the majority of its revenue from the Banking business.